This page is part of the FHIR Specification (v1.4.0: STU 3 Ballot 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
Study protocol example (id = "study")
<Protocol xmlns="http://hl7.org/fhir"> <id value="study"/> <text> <status value="generated"/> <div xmlns="http://www.w3.org/1999/xhtml"> <p> <b>id: </b>study, </p> <p> <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#arm arm-dose1, </p> <p> <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#arm arm-dose2, </p> <p> <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#epoch epoch-screening, </p> <p> <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#epoch epoch-single-blind-run-in, </p> <p> <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#epoch epoch-treatment-phase, </p> <p> <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#epoch epoch-follow-up, </p> <p> <b>status: </b>active, </p> <p> <b>type: </b>study, </p> <p> <b>purpose: </b>Defines the execution of study AD-4833PNFP-341, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.arm, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>SCRN, <b>description: </b>Screen, <b>precondition: </b>, <b>description: </b>Informed Consent, <b>exit: </b>, <b>description: </b>Screening assessments complete, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.arm, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armAssignment, <b>name: </b>SBRI, <b>description: </b>Single Blind Run-In, <b>duration: </b>, <b>value: </b>1, <b>system: </b>http://unitsofmeasure.org, <b>code: </b>wk, <b>precondition: </b>, <b>description: </b>Initial Single Blind Placebo dose, <b>exit: </b>, <b>description: </b>1 week after start of Element, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.arm, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>DOSE 1, <b>description: </b>Administer 0.5mg [Drug A] QD, <b>duration: </b>, <b>value: </b>30, <b>system: </b>http://unitsofmeasure.org, <b>code: </b>wk, <b>precondition: </b>, <b>description: </b>First dose of treatment where total drug dose of [Drug A] per day is 0.5 mg., <b>exit: </b>, <b>description: </b>30 weeks after start of Element, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.arm, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>FLWUP, <b>description: </b>Follow-Up, <b>precondition: </b>, <b>description: </b>Last dose of treatment, <b>exit: </b>, <b>description: </b>2 weeks after start of Element, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.arm, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>SCRN, <b>description: </b>Screen, <b>precondition: </b>, <b>description: </b>Informed Consent, <b>exit: </b>, <b>description: </b>Screening assessments complete, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.arm, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armAssignment, <b>name: </b>SBRI, <b>description: </b>Single Blind Run-In, <b>duration: </b>, <b>value: </b>1, <b>system: </b>http://unitsofmeasure.org, <b>code: </b>wk, <b>precondition: </b>, <b>description: </b>First dose of Single Blind Placebo, <b>exit: </b>, <b>description: </b>1 week after start of Element, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.arm, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>1.0 mg Dose, <b>description: </b>Administer 1.0 mg [Drug A] QD, <b>duration: </b>, <b>value: </b>30, <b>system: </b>http://unitsofmeasure.org, <b>code: </b>wk, <b>precondition: </b>, <b>description: </b>Intial dose of treatment where total drug dose of [Drug A] per day is 1.0 mg., <b>exit: </b>, <b>description: </b>30 weeks after start of Element, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.arm, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>FLWUP, <b>description: </b>Follow-Up, <b>precondition: </b>, <b>description: </b>Last dose of treatment, <b>exit: </b>, <b>description: </b>2 weeks after start of Element, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>VISIT 1, <b>precondition: </b>, <b>description: </b>Screening, <b>activity: </b>, <b>detail: </b>, <b>category: </b>encounter, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>VISIT 2, <b>precondition: </b>, <b>description: </b>single-blind placebo start, <b>activity: </b>, <b>detail: </b>, <b>category: </b>encounter, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>VISIT 3, <b>precondition: </b>, <b>description: </b>Treatment start, <b>activity: </b>, <b>detail: </b>, <b>category: </b>encounter, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>VISIT 4, <b>precondition: </b>, <b>description: </b>5 weeks after treatment start, <b>activity: </b>, <b>detail: </b>, <b>category: </b>encounter, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>VISIT 5, <b>precondition: </b>, <b>description: </b>10 weeks after treatment start, <b>activity: </b>, <b>detail: </b>, <b>category: </b>encounter, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>VISIT 6, <b>precondition: </b>, <b>description: </b>15 weeks after treatment start, <b>activity: </b>, <b>detail: </b>, <b>category: </b>encounter, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>VISIT 7, <b>precondition: </b>, <b>description: </b>20 weeks after treatment start, <b>activity: </b>, <b>detail: </b>, <b>category: </b>encounter, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>VISIT 8, <b>precondition: </b>, <b>description: </b>25 weeks after treatment start, <b>activity: </b>, <b>detail: </b>, <b>category: </b>encounter, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>VISIT 9, <b>precondition: </b>, <b>description: </b>30 weeks after treatment start, <b>activity: </b>, <b>detail: </b>, <b>category: </b>encounter, </p> <p> <b>step: </b>, <b>extension: </b>http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence, <b>name: </b>VISIT 10, <b>precondition: </b>, <b>description: </b>start of follow-up, <b>activity: </b>, <b>detail: </b>, <b>category: </b>encounter, </p> </div> </text> <extension id="arm-dose1" url="http://example.org/example-do-not-use/Profilestudyprotocol#arm"> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#arm.name"> <valueString value="0.5 mg Dose"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#arm.description"> <valueString value="Administering 0.5mg of [Drug A]"/> </extension> </extension> <extension id="arm-dose2" url="http://example.org/example-do-not-use/Profilestudyprotocol#arm"> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#arm.name"> <valueString value="dose2"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#arm.description"> <valueString value="Administering 1.0mg of [Drug A]"/> </extension> </extension> <extension id="epoch-screening" url="http://example.org/example-do-not-use/Profilestudyprotocol#epoch"> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#epoch.name"> <valueString value="Screening"/> </extension> </extension> <extension id="epoch-single-blind-run-in" url="http://example.org/example-do-not-use/Profilestudyprotocol#epoch"> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#epoch.name"> <valueString value="Single blind run-in"/> </extension> </extension> <extension id="epoch-treatment-phase" url="http://example.org/example-do-not-use/Profilestudyprotocol#epoch"> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#epoch.name"> <valueString value="Treatment"/> </extension> </extension> <extension id="epoch-follow-up" url="http://example.org/example-do-not-use/Profilestudyprotocol#epoch"> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#epoch.name"> <valueString value="Follow up"/> </extension> </extension> <status value="active"/> <type value="study"/> <purpose value="Defines the execution of study AD-4833PNFP-341"/> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.arm"> <valueUri value="#arm-dose1"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch"> <valueUri value="#epoch-screening"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="1"/> </extension> <name value="SCRN"/> <description value="Screen"/> <precondition> <description value="Informed Consent"/> </precondition> <exit> <description value="Screening assessments complete"/> </exit> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.arm"> <valueUri value="#arm-dose1"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch"> <valueUri value="#epoch-single-blind-run-in"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="2"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armAssignment"> <valueString value="Randomized to Dose 1"/> </extension> <name value="SBRI"/> <description value="Single Blind Run-In"/> <duration> <value value="1"/> <system value="http://unitsofmeasure.org"/> <code value="wk"/> </duration> <precondition> <description value="Initial Single Blind Placebo dose"/> </precondition> <exit> <description value="1 week after start of Element"/> </exit> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.arm"> <valueUri value="#arm-dose1"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch"> <valueUri value="#epoch-treatment-phase"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="3"/> </extension> <name value="DOSE 1"/> <description value="Administer 0.5mg [Drug A] QD"/> <duration> <value value="30"/> <system value="http://unitsofmeasure.org"/> <code value="wk"/> </duration> <precondition> <description value="First dose of treatment where total drug dose of [Drug A] per day is 0.5 mg."/> </precondition> <exit> <description value="30 weeks after start of Element"/> </exit> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.arm"> <valueUri value="#arm-dose1"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch"> <valueUri value="#epoch-follow-up"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="4"/> </extension> <name value="FLWUP"/> <description value="Follow-Up"/> <precondition> <description value="Last dose of treatment"/> </precondition> <exit> <description value="2 weeks after start of Element"/> </exit> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.arm"> <valueUri value="#arm-dose2"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch"> <valueUri value="#epoch-screening"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="1"/> </extension> <name value="SCRN"/> <description value="Screen"/> <precondition> <description value="Informed Consent"/> </precondition> <exit> <description value="Screening assessments complete"/> </exit> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.arm"> <valueUri value="#arm-dose2"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch"> <valueUri value="#epoch-single-blind-run-in"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="2"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armAssignment"> <valueString value="Randomized to 1.0 mg"/> </extension> <name value="SBRI"/> <description value="Single Blind Run-In"/> <duration> <value value="1"/> <system value="http://unitsofmeasure.org"/> <code value="wk"/> </duration> <precondition> <description value="First dose of Single Blind Placebo"/> </precondition> <exit> <description value="1 week after start of Element"/> </exit> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.arm"> <valueUri value="#arm-dose2"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch"> <valueUri value="#epoch-treatment-phase"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="3"/> </extension> <name value="1.0 mg Dose"/> <description value="Administer 1.0 mg [Drug A] QD"/> <duration> <value value="30"/> <system value="http://unitsofmeasure.org"/> <code value="wk"/> </duration> <precondition> <description value="Intial dose of treatment where total drug dose of [Drug A] per day is 1.0 mg."/> </precondition> <exit> <description value="30 weeks after start of Element"/> </exit> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.arm"> <valueUri value="#arm-pio45mgs"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.epoch"> <valueUri value="#epoch-follow-up"/> </extension> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="4"/> </extension> <name value="FLWUP"/> <description value="Follow-Up"/> <precondition> <description value="Last dose of treatment"/> </precondition> <exit> <description value="2 weeks after start of Element"/> </exit> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="1"/> </extension> <name value="VISIT 1"/> <precondition> <description value="Screening"/> </precondition> <activity> <detail> <category value="encounter"/> </detail> </activity> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="2"/> </extension> <name value="VISIT 2"/> <precondition> <description value="single-blind placebo start"/> </precondition> <activity> <detail> <category value="encounter"/> </detail> </activity> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="3"/> </extension> <name value="VISIT 3"/> <precondition> <description value="Treatment start"/> </precondition> <activity> <detail> <category value="encounter"/> </detail> </activity> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="4"/> </extension> <name value="VISIT 4"/> <precondition> <description value="5 weeks after treatment start"/> </precondition> <activity> <detail> <category value="encounter"/> </detail> </activity> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="5"/> </extension> <name value="VISIT 5"/> <precondition> <description value="10 weeks after treatment start"/> </precondition> <activity> <detail> <category value="encounter"/> </detail> </activity> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="6"/> </extension> <name value="VISIT 6"/> <precondition> <description value="15 weeks after treatment start"/> </precondition> <activity> <detail> <category value="encounter"/> </detail> </activity> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="7"/> </extension> <name value="VISIT 7"/> <precondition> <description value="20 weeks after treatment start"/> </precondition> <activity> <detail> <category value="encounter"/> </detail> </activity> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="8"/> </extension> <name value="VISIT 8"/> <precondition> <description value="25 weeks after treatment start"/> </precondition> <activity> <detail> <category value="encounter"/> </detail> </activity> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="9"/> </extension> <name value="VISIT 9"/> <precondition> <description value="30 weeks after treatment start"/> </precondition> <activity> <detail> <category value="encounter"/> </detail> </activity> </step> <step> <extension url="http://example.org/example-do-not-use/Profilestudyprotocol#step.armSequence"> <valueInteger value="10"/> </extension> <name value="VISIT 10"/> <precondition> <description value="start of follow-up"/> </precondition> <activity> <detail> <category value="encounter"/> </detail> </activity> </step> </Protocol>
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.